The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials
Open accessAbstract
Over the past decade, the rate of drug attrition due to clinical trial failures has risen substantially. Unfortunately it is difficult to identify compounds that have unfavorable toxicity properties before conducting clinical trials. Inspired by the effective use of sabermetrics in predicting successful baseball players, we sought to use a similar "moneyball" approach that analyzes overlooked features to predict clinical toxicity. We introduce a new data-driven approach (PrOCTOR) that directly predicts the likelihood of toxicity in clinical trials. PrOCTOR integrates the properties of a compound's targets and its structure to provide a new measure, the PrOCTOR score. Drug target network connectivity and expression levels, along with molecular weight, were identified as important indicators of adverse clinical events. Our method provides a data-driven, broadly applicable strategy to identify drugs likely to possess manageable toxicity in clinical trials and will help drive the design of therapeutic agents with less toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while efficacy is as complex to predict6.”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [6]
In the citing paper
“Gayvert et al. performed classified toxicity prediction on FDA-approved drugs and drugs that had failed to pass toxicity-tests, with the RF supervised learning algorithm. The learning was from multiple sources: chemical structure characterizations, the median value of the expression of the drug targeted genes from the transcriptome of various tissues, the frequency or possibility of functional”
From Machine Learning Based Toxicity Prediction: From Chemical Structural Description to Transcriptome Analysis (2018) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
The igraph software package for complex network research
Csárdi, G., & Nepusz, T. (2006) · Medical Entomology and Zoology · Cited by 10,078
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,455
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1998) · Journal of Combinatorial Chemistry · doi:10.1021/cc9800071 · Cited by 3,095
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 310
Quest for discovering novel CDK12 inhibitor
Debnath, A., Singh, R. K., Mazumder, R., Mazumder, A., Srivastava, S., Chaudhary, H., Mangal, S., Sanchitra, J., Tyagi, P. K., Singh, S. K., et al. (2024) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2024.2441185 · Cited by 3
Machine Learning: A Tool to Shape the Future of Medicine
Hazapi, O., Lаgopati, N., Pezoulas, V. C., Papayiannis, G. I., Fotiadis, D. I., Skaltsas, D., Vergetis, V., Tsirigos, A., Stratis, I. G., Yannacopoulos, A. N., et al. (2022) · Studies in big data · doi:10.1007/978-981-16-9158-4_12 · Cited by 3
Artificial intelligence in small-molecule drug discovery
Martinelli, C., Repetto, M., & Curigliano, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13671-9.00012-0 · Cited by 3
Predicting clinical trial success for Clostridium difficile infections based on preclinical data
Li, F., Youn, J., Millsop, C., & Tagkopoulos, I. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1487335 · Cited by 2
TRANSFORMATIVE APPLICATIONS OF AI IN HEALTHCARE AND PHARMACEUTICAL INNOVATION
JASMINE, P., IBRAHIM, A., Siddiq, S., DHANURSHRA, A., NIRMALA, M., & BASHA, S. S. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i3.52719 · Cited by 2
Knowledge graph information bottleneck enhanced molecular representation learning
Dai, J., Fu, D., Qiu, Z., Ma, L., & Zhang, D. (2025) · Neural Networks · doi:10.1016/j.neunet.2025.107560 · Cited by 2
Trialblazer: A chemistry-focused predictor of toxicity risks in late-stage drug development
Zhang, H., Welsch, M., Schueller, W., & Kirchmair, J. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118306 · Cited by 2
Lou, X., Cai, J., & Siu, S. W. I. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01126-w · Cited by 2
Update and ADMET Profile of the Latin American Natural Product Database: LANaPDB
Gómez‐García, A., Lavecchia, M. J., Olmedo, D. A., Solís, P. N., & Medina‐Franco, J. L. (2025) · Molecular Informatics · doi:10.1002/minf.70013 · Cited by 2
Prediction of drug approvals in oncology using explainable artificial intelligence
Watanabe, T., Nemoto, S., Kato, H., & Isomura, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-31939-6 · Cited by 2
Nanoinformatics‐Based, Predictive Toxicological Screening of Nanomaterials
Adil, M., Tiwari, P., & Kanwal, S. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70112 · Cited by 2
A large-scale database for clinical trial outcomes and features
Gao, C., Pradeepkumar, J., Das, T., Thati, S., & Sun, J. (2026) · Nature Health · doi:10.1038/s44360-026-00081-6 · Cited by 18
Li, W., & Bischel, H. N. (2026) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6c00172 · Cited by 2
AI Driven Computational Nanomedicine for Personalized Cancer Therapy
Farghama, K., Khan, M. S., Wajid, M., & Shaffique, S. (2026) · BioNanoScience · doi:10.1007/s12668-026-02681-8 · Cited by 2
Prospective adverse event risk evaluation in clinical trials
Kundu, A., Feijoo, F., Martínez, D. A., Hermosilla, M., & Matis, T. I. (2021) · Health Care Management Science · doi:10.1007/s10729-021-09584-y · Cited by 2
Targeting GPCRs Via Multi-Platform Arrays and AI
Preto, A. J., Marques-Pereira, C., Baptista, S. J., Bueschbell, B., Barreto, C. A. V., Gaspar, A. T., Pinheiro, I., Pereira, N. N., Pires, M., Ramalhão, D., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00048-7 · Cited by 2
Arivanantham, S., Sekar, P., Sundhararajan, N., Nagalingam, Y., & Raju, S. K. (2023) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2023.16.2.0467 · Cited by 2
Artificial intelligence in cancer research and precision medicine
Corti, C., Cobanaj, M., Criscitiello, C., & Curigliano, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13671-9.00005-3 · Cited by 3
Lu, Y., Wang, C., Wang, Z., Zhang, X., Zhou, G., & Li, C. (2024) · Alexandria Engineering Journal · doi:10.1016/j.aej.2024.11.110 · Cited by 3
Barrero, J. A., & Clavijo, A. ́. G. (2022) · Revista Colombiana de Ciencias Químico Farmacéuticas · doi:10.15446/rcciquifa.v51n1.102679 · Cited by 2
Artificial Intelligence (AI) in Drug Discovery and Medicine
Varun, A. (2019) · Journal of Clinical Cases & Reports · doi:10.46619/joccr.2019.2-1043 · Cited by 2
Adaptive graph convolutional neural network and its biomedical applications
Huang, J., & Li, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-819872-8.00012-4 · Cited by 2
Kantak, M., & Shende, P. K. (2023) · Toxicology Research · doi:10.1093/toxres/tfad001 · Cited by 1
Computational Approaches: A New Frontier in Cancer Research
Srivastava, S., & Jain, P. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073265604231106112203 · Cited by 1
Molecular representation learning based on Transformer with fixed-length padding method
Wu, Y., Yang, Y., Zhang, R., Chen, Z., Jin, M., Zou, Y., Wang, Z., & Wu, F. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.139574 · Cited by 1
Bhatt, J. A., Morris, K. R., & Haware, R. V. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02970-z · Cited by 1
Zhao, H., Liang, X., Xie, C., & Wang, S. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3547315 · Cited by 1
Berre, C. L., Jairath, V., Panaccione, R., Bourreille, A., Magro, F., Danese, S., & Peyrin‐Biroulet, L. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.01.030 · Cited by 2
Exploring the Efficacy of Large Language Models in Predicting Chemical Toxicity
Chung, Y.-H., Tung, C.-W., & Chang, Y. (2025) · Lecture notes in computer science · doi:10.1007/978-981-96-8889-0_35 · Cited by 1
Guerrero‐Alonso, A., González‐Maya, L., Sánchez‐Carranza, J. N., Marbán‐González, A., Marquina, S., Álvarez, L., & Antunez‐Mojica, M. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.102200 · Cited by 1
Deep learning for toxicity prediction
Miao, Y., & Huang, J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-44-332908-1.00028-3 · Cited by 1
Hall, S. S., Riga, E., Mitchell, E. J., Thomson, L., Taylor, J., Carr, L., Hagan, P., & Sprange, K. (2025) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2025.101556 · Cited by 1
Feature-enhanced graph neural network with multiple attention for molecular property prediction
Qin, B., Zhu, X., Fan, C.-Y., Xue, X., Wang, M., & Tang, H. (2025) · Neurocomputing · doi:10.1016/j.neucom.2025.132426 · Cited by 1
Korolev, V., Sorokin, A. A., & Kuratov, Y. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02342 · Cited by 1
Transforming drug development with AI-driven models
Pathak, S., & Garg, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34059-8.00008-7 · Cited by 1
AI-designed drugs: clinical development and future directions
Ahmed, R., Akhtar, S., Das, A., Begum, K., Sarma, A., Chakraborty, A., Neog, T., & Banu, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34059-8.00010-5 · Cited by 1
Success rates of American clinical oncology trials by geographic factors
Patiyal, S., & Schäffer, A. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-39609-x · Cited by 1
Liu, Z., Zhou, S., Liu, T., Liu, C. X., Zang, M., & Wang, Q. (2026) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2026.2661853 · Cited by 1
Functional Groups Are All You Need for Chemically Interpretable Molecular Property Prediction
Balaji, R., Bobby, J., & Bhatt, N. P. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02769 · Cited by 3
Forecasting novel therapeutic development in biomedical research
Arabi, S., & Hutchins, B. I. (2026) · Communications Medicine · doi:10.1038/s43856-026-01838-6 · Cited by 4
Artificial neural network–based inference of drug–target interactions
Melamane, S., Mandava, T. T., Manda, A., Luphade, L. N., Khamanga, S. M., Makoni, P. A., Demana, P. H., Matafwali, S. K., & Witika, B. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91763-6.00015-1 · Cited by 2
Pan, X., Lian, X., Zhu, J., Lv, T., Hong, X., Ding, L., Ni, J., Jiang, C., & Ni, J. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3416348 · Cited by 1
MulAFNet: Integrating Multiple Molecular Representations for Enhanced Property Prediction
Ci, L., Li, B., Xu, J., Peng, S., Jiang, L., & Long, W. (2025) · ACS Omega · doi:10.1021/acsomega.4c09884 · Cited by 6
Starting Anti-COVID-19 Drug Discovery with Natural Products
Silva, O. N., Neves, B. J., Rosseto, L. P., de Moura, R. S., Napolitano, H. B., Brito, W. D. A., Fajemiroye, J. O., Pinto, E., Perjési, P., & Martins, J. L. R. (2021) · Fronteiras Journal of Social Technological and Environmental Science · doi:10.21664/2238-8869.2021v10i1.p241-270
An Analysis of Attentive Walk-Aggregating Graph Neural NetworksPreprint
Demirel, M. F., Liu, S., Garg, S., & Liang, Y. (2021) · arXiv (Cornell University) · Cited by 1
Faculty Opinions recommendation of A deep learning approach to antibiotic discovery.
Watkins, R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737402248.793572001 · Cited by 1
Predicting FDA approvability of small-molecule drugsPreprint
Huang, C.-H., Hsu, J., Yang, L.-Y., Chen, T., Shih, E. S. C., & Hwang, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.15.512330 · Cited by 1
A Novel Atom Pair Attention Methodology for MolecularRepresentation LearningPreprint
Sun, H., Jiang, Y., Wang, M., Xiao, X., Wan, X., Tang, M., Jin, X., Niu, Z., & Chen, H. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-3b0js · Cited by 1
LLM4TOP: An End-to-End framework based on Large Language Model for trial outcome predictionPreprint
Qian, L., Lu, X., Haris, P. I., Shuo, L., Zhu, J., & Yang, Y. (2025) · medRxiv · doi:10.1101/2025.07.06.25330956 · Cited by 1
Structure-based analysis of curcumin and conventional drugs targeting tumor-inducing protein PHF20
Agrawal, V., Mishra, A., Tiwari, S., & Srivastava, A. K. (2018) · Bioinformation · doi:10.6026/97320630014477
Transforming Drug Discovery for Aging Research with AI-Based Integrated Approaches
Vanhaelen, Q. (2020) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20200010
Dinakaran, S., & Anitha, P. M. (2020) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-020-02275-6
RetractedPredicting the Toxicity of Druggable Proteins to Human TissuesPreprint
Hao, Y., Thangaraj, P., & Tatonetti, N. P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.07.471637
Faculty Opinions recommendation of A deep learning approach to antibiotic discovery.
Swinney, D. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737402248.793576936
Babu, M. M., & Marti, M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735476043.793566834
Flannick, J. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735476043.793563024
Kim, S., Park, M., Kim, D., Kim, I., & Im, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1932224/v1
Biología de sistemas y computacional en cáncer: de lo básico a la próxima frontera
Cardona, A. F., Pino, L. E., & Cantor, E. A. (2022) · Medicina · doi:10.56050/01205498.1651
Sandjakoska, L., Bogdanova, A. M., & Pejov, L. (2022) · Communications in computer and information science · doi:10.1007/978-3-031-22792-9_13
A Novel Atom Pair Attention Methodology for Molecular Representation LearningPreprint
Sun, H., Jiang, Y., Wang, M., Xiao, X., Wan, X., Tang, M., Jin, X., Niu, Z., & Chen, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2418652/v1
The Structure-property Relationships of Clinically Approved Protease Inhibitors
Choi, K. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230409232655 · Cited by 1
Artificial Intelligence used in Pharmaceutical and Healthcare Industry: A Review
Goswami, S., & Singh, M. K. (2023) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-12471 · Cited by 2
Hardware/Software Coexploration for Hyperdimensional Computing on Network-on-Chip Architecture
Yang, J., & Yang, L. (2023) · IEEE Design and Test · doi:10.1109/mdat.2023.3309733
Pan, X., Lian, X., Zhu, J., Lv, T., Hong, X., Ding, L., Li, L., Jiang, C., & Ni, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3488751/v1
Fast and effective molecular property prediction with transferability mapPreprint
Feng, Z., Yao, S., Song, J., Jia, L., Cheng, L., Zhong, Z., & Song, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3565603/v1
Wei, L., Ci, L., Hu, L., Xu, J., Peng, S., & Jiang, L. (2023) · Research Square · doi:10.21203/rs.3.rs-3690402/v1
A COMPREHENSIVE REVIEW: EXPLORING ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY AND DEVELOPMENT
(2024) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets48342
Artificial Intelligence for Drug Toxicity and Safety
Joshi-Barr, S., & Wampole, M. E. (2023) · Springer eBooks · doi:10.1007/978-3-030-73317-9_134-1
Kumar, A., Prasad, S., & Kumar, K. N. P. (2023) · IEEE Asia-Pacific Conference on Computer Science and Data Engineering (CSDE) · doi:10.1109/csde59766.2023.10487734
Facilitating Feature Selection and Extraction in Clinical Trials with Large Language Models
Guo, J., Sun, W., Wen, S., Wu, D., & Zhou, Y. (2024) · Lecture notes in computer science · doi:10.1007/978-981-96-0840-9_16
Comprehensive Analysis of Masking Techniques in Molecular Graph Representation Learning
Koo, B., & Kwon, S. (2025) · IEEE Access · doi:10.1109/access.2025.3531302 · Cited by 1
A two-stage framework by leveraging large language model for predicting clinical trial outcomes
Kan, B., Zhu, H., Weng, H., Zeng, K., Wang, F. L., & Hao, T. (2025) · Intelligent Data Analysis · doi:10.1177/1088467x251330470
Enhancing Molecular Contrastive Prediction by Recognizing Metric Distribution Separation
Liu, X., & Sun, D. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3580460
Scaling Molecular Representation Learning with Hierarchical Mixture-of-ExpertsPreprint
Zhang, X., Yu, S., Xia, J., & Yang, F. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.09.669511
FusionCLM: enhanced molecular property prediction via knowledge fusion of chemical language models
Lu, Y., Li, Y. Y., Sun, Y., & Hu, P. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01073-6
PyaiVS unifies AI workflows to accelerate ligand discovery and yields ABCG2 inhibitors
Wang, M., Qu, B., Yang, L., Wang, L., Jiang, K., & Lin, J. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118176 · Cited by 1
Ontology pre-training improves machine learning-based predictions for metabolitesPreprint
Tumescheit, C., Glauer, M., Flügel, S., Larralde, M. F., Neuhaus, F., Mossakowski, T., & Hastings, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.30.679573
Implementation of Firefly Algorithm-Support Vector Machine in Classifying Clinical Trial Toxicity
Mahardika, R. A., & Kurniawan, I. (2025) · doi:10.1109/icoict66265.2025.11193023
Dezső, Z., & Ceccarelli, M. (2020) · Figshare · doi:10.6084/m9.figshare.11986335
Dezső, Z., & Ceccarelli, M. (2020) · Figshare · doi:10.6084/m9.figshare.11986329
Dezső, Z., & Ceccarelli, M. (2020) · Figshare · doi:10.6084/m9.figshare.11986332
Liu, C., Sun, Y., Davis, R. L., Cardona, S. T., & Hu, P. (2024) · Figshare · doi:10.6084/m9.figshare.26571487
Contrastive Learning Approaches for Drug Discovery
Sanchez-Fernandez, A., & Klambauer, G. (2026) · Springer eBooks · doi:10.1007/978-3-031-98022-0_15
MMPCS: multi-view molecular pretraining based on consistency information and specific information
Xie, C., Song, Y., He, S., Bo, X., & Zhang, Z. (2026) · Bioinformatics · doi:10.1093/bioinformatics/btag028
Guzman, C. D. I. D., Perfinian, G. C., Alseekh, S., Fernie, A. R., Tiozon, R. N., & Sreenivasulu, N. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108610
Zhuang, L., Sun, Y., Zhao, J., & Wang, H. (2026) · Applied Soft Computing · doi:10.1016/j.asoc.2026.115106
Petrosyan, N., Matevosyan, H., Tirosyan, I., Gabrielyan, Y., Gevorgyan, S., Harutyunyan, V., Matevosyan, M., & Zakaryan, H. S. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c02953
Singh, P. K., Kumar, I., Kumar, U., Singh, R. P., Singh, R. S., & Sharma, R. K. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.128415
Organic Materials of Tomorrow: Horizons of Artificial Intelligence
Mena, H., Blaskovits, J. T., Lin, K., & Andrienko, D. (2026) · Advanced Materials · doi:10.1002/adma.202523667
Chain, C., Ghaffari, S., Belakaria, S., Sheehan, J. P., Irani, I., Wu, C.-Y., Kim, H., Engelhardt, B. E., & Gitai, Z. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.08.730938
Dai, J., Fu, D., Qiu, Z., Ma, L., & Zhang, D. (2026) · Expert Systems with Applications · doi:10.1016/j.eswa.2026.133312
Jafarabadi, M. A., Myles, P. S., Coulson, T. G., Winter, N., Corcoran, T. B., Chan, M. T. V., Wu, W. K. K., Peyton, P. J., Leslie, K., & Forbes, A. B. (2026) · BJA Open · doi:10.1016/j.bjao.2026.100570
MolPACL: Molecular Property Prediction Based on Prompt Augmentation and Contrastive Learning
Forooghi, A., Rueda, L. G., & Ngom, A. (2026) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2026.3723323
Task-Specific Sparse Feature Masks for Molecular Toxicity Prediction with Chemical Language Models
Lee, K. S., Chen, J., Chung, F. S. F., Zhao, T., Chen, Z., & Wang, D. D. (2026) · International Conference on Bioinformatics and Computational Biology (ICBCB) · doi:10.1109/icbcb69424.2026.11621727
Kan, B., Wang, T., Qu, Y., Wang, F. L., & Hao, T. (2026) · Neurocomputing · doi:10.1016/j.neucom.2026.134680
Applications in Modern Research
Badal, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-28873-8_6
Yang, Z. (2026) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2026.105849
Wu, Y., Jiang, Y., Qi, X., Fu, H., Tang, Q., Wang, W., Zeng, C., & Zhu, G. (2026) · Molecules · doi:10.3390/molecules31173008
Is One Molecular Representation Enough? A Comparative Study of Geometry-Based Featurization MethodsPreprint
Ali, M. S., & Bano, S. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7360160
Metadata
- Authors
- Gayvert, K. M., Madhukar, N. S., & Elemento, O.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Weill Cornell Medicine (US)
- Corresponding author
- Elemento, Olivier
- Venue
- Cell chemical biology
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 23
- Issue
- 10
- Pages
- 1294-1301
- ISSN
- 2451-9448 (ISSN-L)
- 2451-9456
- PMC
- PMC5074862
- OpenAlex
- W2461620095
- Cited by
- 310
- References
- 30
- Citations by year
- 2026: 46 · 2025: 48 · 2024: 49 · 2023: 52 · 2022: 33 · 2021: 30 · 2020: 29 · 2019: 13 · 2018: 8 · 2017: 1 · 2016: 1
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell chemical biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- CAREER grant from National Science Foundation (DB1054964)
- NIH (R01CA194547)
- Starr Cancer Foundation
- Institute for Computational Biomedicine
- PhRMA Foundation Pre Doctoral Informatics Fellowship
- Tri-Institutional Training Program in Computational Biology and Medicine
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- drug attrition, molecular weight, adverse clinical events, structure-property relationships, drug toxicity
- MeSH terms
- Clinical Trials as Topic, Humans, Models, Biological, Models, Molecular, Software, Likelihood Functions, Computational Biology, Drug Discovery, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review